We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Veeva's Vault CDMS to Unify Clinical Data in Single Platform
Read MoreHide Full Article
Veeva Systems Inc. (VEEV - Free Report) recently announced that its next-generation cloud single clinical data management application, Veeva Vault CDMS, eliminates the need for multiple tools and helps streamline clinical data. Thus, healthcare companies can now get a complete view of clinical data in a single application and move away from a complex combination of data.
Following the announcement, Veeva’s shares inched up 0.7% to $105.20. Over the past year, shares of this California-based company have rallied 89.2% compared with the industry’s 35% rise. The current level is also higher than the S&P 500 index’s gain of 16.3%.
The stock currently carries a Zacks Rank #2 (Buy).
About Veeva Vault CDMS
Vault CDMS is part of Veeva Vault Clinical Suite platform. The modern cloud-based application combines the Vault Coder, Vault EDC and Vault Data Workbench. The Vault Coder codes medical information with speed and accuracy in Vault CDMS. Meanwhile, the Vault EDC maintains and manages all clinical data.
Per management, the Vault Data Workbench is designed to seamlessly bring together all trial data for integrated cleaning, reporting and export. It is scheduled to be available starting 2019.
Cloud-Based Computing Takes MedTech by Storm
Healthcare companies are increasingly relying on cloud-based applications to streamline healthcare data. Cloud-based applications are cost effective and help streamline operations through the use of electronic health records, electronic medical records and predictive analytics.
Other bigwigs that offer cloud-based services are Cerner Corporation and athenahealth . Cerner’s HealtheIntent and athenahealth’s cloud-based big data network athenaNet deserve a mention here.
Market Prospects
Per research by MarketsandMarkets, the global healthcare cloud computing market is expected to reach $44.93 billion by 2023 at a CAGR of 18.2%. The study further states that in 2018, North America held the largest share of the healthcare cloud computing market, followed by Europe.
Thus, Veeva’s latest move has been a timely and strategic one.
It's hard to believe, even for us at Zacks. But while the market gained +21.9% in 2017, our top stock-picking screens have returned +115.0%, +109.3%, +104.9%, +98.6%, and +67.1%.
And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - 2017, the composite yearly average gain for these strategies has beaten the market more than 19X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation.
Image: Bigstock
Veeva's Vault CDMS to Unify Clinical Data in Single Platform
Veeva Systems Inc. (VEEV - Free Report) recently announced that its next-generation cloud single clinical data management application, Veeva Vault CDMS, eliminates the need for multiple tools and helps streamline clinical data. Thus, healthcare companies can now get a complete view of clinical data in a single application and move away from a complex combination of data.
Following the announcement, Veeva’s shares inched up 0.7% to $105.20. Over the past year, shares of this California-based company have rallied 89.2% compared with the industry’s 35% rise. The current level is also higher than the S&P 500 index’s gain of 16.3%.
The stock currently carries a Zacks Rank #2 (Buy).
About Veeva Vault CDMS
Vault CDMS is part of Veeva Vault Clinical Suite platform. The modern cloud-based application combines the Vault Coder, Vault EDC and Vault Data Workbench. The Vault Coder codes medical information with speed and accuracy in Vault CDMS. Meanwhile, the Vault EDC maintains and manages all clinical data.
Per management, the Vault Data Workbench is designed to seamlessly bring together all trial data for integrated cleaning, reporting and export. It is scheduled to be available starting 2019.
Cloud-Based Computing Takes MedTech by Storm
Healthcare companies are increasingly relying on cloud-based applications to streamline healthcare data. Cloud-based applications are cost effective and help streamline operations through the use of electronic health records, electronic medical records and predictive analytics.
Earlier this year, Veeva launched Nitro, a next-generation commercial data warehouse for the life sciences industry. (Read More: Veeva Rolls Out Nitro to Unify Healthcare Industry Data)
Other bigwigs that offer cloud-based services are Cerner Corporation and athenahealth . Cerner’s HealtheIntent and athenahealth’s cloud-based big data network athenaNet deserve a mention here.
Market Prospects
Per research by MarketsandMarkets, the global healthcare cloud computing market is expected to reach $44.93 billion by 2023 at a CAGR of 18.2%. The study further states that in 2018, North America held the largest share of the healthcare cloud computing market, followed by Europe.
Thus, Veeva’s latest move has been a timely and strategic one.
Another Key Pick
Another top-ranked stock in the broader medical space is Intuitive Surgical, Inc. (ISRG - Free Report) , with a Zacks Rank #2. Intuitive Surgical’s long-term earnings growth is projected at 14.7%. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Today's Stocks from Zacks' Hottest Strategies
It's hard to believe, even for us at Zacks. But while the market gained +21.9% in 2017, our top stock-picking screens have returned +115.0%, +109.3%, +104.9%, +98.6%, and +67.1%.
And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - 2017, the composite yearly average gain for these strategies has beaten the market more than 19X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation.
See Them Free>>